Results 81 to 90 of about 12,446 (175)

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages. [PDF]

open access: yesVaccines (Basel), 2022
Dos Santos CC   +8 more
europepmc   +1 more source

Vaccine-Induced Subcutaneous Granulomas in Goats Reflect Differences in Host-Mycobacterium Interactions between BCG- and Recombinant BCG-Derivative Vaccines. [PDF]

open access: yesInt J Mol Sci, 2022
Liebler-Tenorio EM   +9 more
europepmc   +1 more source

Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice. [PDF]

open access: yesFront Immunol, 2022
Trentini MM   +6 more
europepmc   +1 more source

Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii. [PDF]

open access: yesVaccines (Basel), 2021
Komine-Aizawa S   +5 more
europepmc   +1 more source

Expression of recombinant antigen in BCG.

open access: yes, 2000
Little is known about the effect of different modes of expression of an antigen in rBCG on immune response. An appropriate wing of the immune system, with different degrees, is activated upon encounter with a foreign antigen. Knowledge of these responses is vital to the development of future recombinant vaccine. Various E.
openaire   +1 more source

Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice. [PDF]

open access: yesVaccines (Basel), 2022
Fol M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy